Celsius (NASDAQ:CELH) Price Target Cut to $85.00 by Analysts at Stifel Nicolaus

Celsius (NASDAQ:CELH) had its target price reduced by Stifel Nicolaus from $95.00 to $85.00 in a research note released on Thursday morning, Benzinga reports. They currently have a buy rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Roth Mkm boosted their price objective on shares of Celsius from $90.00 to $105.00 and gave the company a buy rating in a research report on Thursday, March 14th. Maxim Group upped their price target on Celsius from $100.00 to $110.00 and gave the stock a buy rating in a research report on Monday, April 1st. Wedbush lifted their price objective on Celsius from $75.00 to $90.00 and gave the company an outperform rating in a research report on Monday, March 4th. Morgan Stanley reissued an equal weight rating and issued a $75.00 target price on shares of Celsius in a report on Wednesday, March 27th. Finally, Jefferies Financial Group lifted their price target on shares of Celsius from $98.00 to $105.00 and gave the company a buy rating in a report on Monday, March 18th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average target price of $85.45.

Celsius Price Performance

Celsius stock traded up $1.59 during midday trading on Thursday, reaching $75.97. 4,214,836 shares of the company traded hands, compared to its average volume of 3,531,141. The firm has a market capitalization of $17.55 billion, a price-to-earnings ratio of 98.24, a price-to-earnings-growth ratio of 2.22 and a beta of 1.93. The business has a 50 day moving average of $80.79 and a two-hundred day moving average of $65.52. Celsius has a 12 month low of $32.99 and a 12 month high of $99.62.

Celsius (NASDAQ:CELH) last released its quarterly earnings results on Thursday, February 29th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. The firm had revenue of $347.44 million during the quarter, compared to analyst estimates of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The business’s revenue for the quarter was up 95.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.01 EPS. As a group, equities analysts forecast that Celsius will post 1.09 EPS for the current year.

Insider Activity

In related news, CFO Jarrod Langhans sold 4,079 shares of the business’s stock in a transaction dated Friday, April 19th. The stock was sold at an average price of $69.42, for a total value of $283,164.18. Following the sale, the chief financial officer now directly owns 83,670 shares in the company, valued at $5,808,371.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Celsius news, CFO Jarrod Langhans sold 4,079 shares of Celsius stock in a transaction that occurred on Friday, April 19th. The stock was sold at an average price of $69.42, for a total value of $283,164.18. Following the sale, the chief financial officer now owns 83,670 shares of the company’s stock, valued at approximately $5,808,371.40. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, major shareholder William H. Milmoe sold 428,568 shares of the stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $59.67, for a total value of $25,572,652.56. Following the transaction, the insider now owns 25,464,453 shares of the company’s stock, valued at $1,519,463,910.51. The disclosure for this sale can be found here. Insiders sold a total of 1,186,215 shares of company stock worth $80,215,119 over the last 90 days. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of Celsius

A number of large investors have recently made changes to their positions in CELH. Commonwealth Equity Services LLC increased its stake in Celsius by 93.1% during the third quarter. Commonwealth Equity Services LLC now owns 106,706 shares of the company’s stock worth $18,311,000 after acquiring an additional 51,451 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in shares of Celsius by 89.1% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 16,386 shares of the company’s stock valued at $2,812,000 after purchasing an additional 7,723 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its holdings in Celsius by 8.0% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 53,237 shares of the company’s stock valued at $9,135,000 after buying an additional 3,921 shares during the period. Bank of New York Mellon Corp lifted its position in Celsius by 8.5% in the third quarter. Bank of New York Mellon Corp now owns 428,602 shares of the company’s stock worth $73,548,000 after buying an additional 33,597 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Celsius by 48.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,100 shares of the company’s stock worth $1,390,000 after buying an additional 2,643 shares during the period. 60.95% of the stock is currently owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.